Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,201 to 1,220 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01GM120351 | Effects of lipidomic diversity on GPCR | 1 | 2021 |
| R01GM126130 | Allostery in an intrinsically disordered transcription factor | 1 | 2021 |
| R01GM126299 | High Resolution Modeling and Design of T-Cell Receptors | 1 | 2021 |
| R01GM129357 | Molecular mechanisms of TRPV5 gating | 1 | 2021 |
| R01HG007175 | DECODING THE IMPACT OF TRANSPOSABLE ELEMENTS ON GENE REGULATION | 1 | 2021 |
| R01HL113956 | Understanding Severe Asthma Using an Experimental Model | 1 | 2021 |
| R01HL134830 | Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy | 1 | 2021 |
| R01HL135156 | Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children | 1 | 2021 |
| R01HL136314 | Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis | 1 | 2021 |
| R01HL137919 | The Interferon-beta (IFN-beta)/SETDB2 Epigenetic Axis Regulates Inflammation And Metabolism In Diabetic Wounds | 1 | 2021 |
| R01HL140470 | Complement driven innate and adaptive autoreactivity in lung transplantation | 1 | 2021 |
| R01HL143520 | Role of Cul4A in Governing Th2-Type Tolerance | 1 | 2021 |
| R01HL144396 | Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma | 1 | 2021 |
| R01LM012595 | Reconstruction and Modeling of Dynamical Molecular Networks | 1 | 2021 |
| R01NS097719 | A Nomogram to Predict Seizure Outcomes after Resective Epilepsy Surgery | 1 | 2021 |
| R01NS102444 | Signaling mechanism for synapse formation and function regulated by the release of GPI-anchored synaptogenic factors from astrocytes | 1 | 2021 |
| R21AI144315 | Mechanisms of immune dysregulation in human PI3Kgamma deficiency | 1 | 2021 |
| R21AI145304 | Genetics of organ-specific lupus disease sequelae | 1 | 2021 |
| R21AI148982 | MHC class II presentation of Borrelia burgdorferi and synovial tissue antigens in murine Lyme arthritis | 1 | 2021 |
| R21CA245432 | Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=61